12
Bloomberg journalist Sam Fasely named the reasons for trusting the Russian vaccine against COVID-19 Sputnik V. This was reported by RIA Novosti with reference to the publication's journalist Sam Fasely.
According to him, the vaccine has passed the third phase of clinical trials, and the effectiveness of the drug has exceeded 90 percent. In addition, the journalist stressed that the tests did not reveal cases of a severe course of the disease.
According to Fasely, despite the fact that Russia has not published data on the vaccine in scientific journals, the available information allows the Sputnik V vaccine to be placed on a par with its Western counterparts.
